AI Verdict
NEU has stronger fundamentals based on our AI analysis.
NEUP vs NEU Fundamental Comparison
| Metric | NEUP | NEU |
|---|---|---|
| Revenue | $15.6M | $2.7B |
| Net Income | $-8.0M | $418.7M |
| Net Margin | -51.4% | 15.4% |
| ROE | -27.1% | 23.5% |
| ROA | -22.0% | 12.0% |
| Current Ratio | 9.04x | 2.53x |
| Debt/Equity | 0.00x | 0.50x |
| EPS | $-2.66 | $44.44 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NEUP vs NEU: Frequently Asked Questions
Is NEUP or NEU a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NEU has stronger fundamentals. NEUP is rated SELL (68% confidence) while NEU is rated BUY (78% confidence). This is not investment advice.
How does NEUP compare to NEU fundamentally?
Neuphoria Therapeutics Inc. has ROE of -27.1% vs NEWMARKET CORP's 23.5%. Net margins are -51.4% vs 15.4% respectively.
Which stock pays higher dividends, NEUP or NEU?
NEUP has a dividend yield of N/A or no dividend while NEU has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NEUP or NEU for long term?
For long-term investing, consider that NEUP has SELL rating with 68% confidence, while NEU has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NEUP vs NEU?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NEUP vs NEU, the AI consensus favors NEU based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.